380 related articles for article (PubMed ID: 10903781)
1. Dynamics of HIV-specific CD8+ T lymphocytes with changes in viral load.The RESTIM and COMET Study Groups.
Mollet L; Li TS; Samri A; Tournay C; Tubiana R; Calvez V; Debré P; Katlama C; Autran B
J Immunol; 2000 Aug; 165(3):1692-704. PubMed ID: 10903781
[TBL] [Abstract][Full Text] [Related]
2. Decay kinetics of human immunodeficiency virus-specific CD8+ T cells in peripheral blood after initiation of highly active antiretroviral therapy.
Casazza JP; Betts MR; Picker LJ; Koup RA
J Virol; 2001 Jul; 75(14):6508-16. PubMed ID: 11413318
[TBL] [Abstract][Full Text] [Related]
3. Frequency of class I HLA-restricted anti-HIV CD8+ T cells in individuals receiving highly active antiretroviral therapy (HAART).
Gray CM; Lawrence J; Schapiro JM; Altman JD; Winters MA; Crompton M; Loi M; Kundu SK; Davis MM; Merigan TC
J Immunol; 1999 Feb; 162(3):1780-8. PubMed ID: 9973442
[TBL] [Abstract][Full Text] [Related]
4. Recognition patterns of HLA-A2-restricted human immunodeficiency virus-1-specific cytotoxic T-lymphocytes in a cohort of HIV-1-infected individuals.
Schmitt-Haendle M; Bachmann O; Harrer E; Schmidt B; Bäuerle M; Harrer T
Viral Immunol; 2005; 18(4):627-36. PubMed ID: 16359229
[TBL] [Abstract][Full Text] [Related]
5. Specificity of T cells in synovial fluid: high frequencies of CD8(+) T cells that are specific for certain viral epitopes.
Tan LC; Mowat AG; Fazou C; Rostron T; Roskell H; Dunbar PR; Tournay C; Romagné F; Peyrat MA; Houssaint E; Bonneville M; Rickinson AB; McMichael AJ; Callan MF
Arthritis Res; 2000; 2(2):154-64. PubMed ID: 11062606
[TBL] [Abstract][Full Text] [Related]
6. Human CD28-CD8+ T cells contain greatly expanded functional virus-specific memory CTL clones.
Weekes MP; Carmichael AJ; Wills MR; Mynard K; Sissons JG
J Immunol; 1999 Jun; 162(12):7569-77. PubMed ID: 10358214
[TBL] [Abstract][Full Text] [Related]
7. Functional restoration of human immunodeficiency virus and Epstein-Barr virus-specific CD8(+) T cells during highly active antiretroviral therapy is associated with an increase in CD4(+) T cells.
Kostense S; Otto SA; Knol GJ; Manting EH; Nanlohy NM; Jansen C; Lange JM; van Oers MH; Miedema F; van Baarle D
Eur J Immunol; 2002 Apr; 32(4):1080-9. PubMed ID: 11920575
[TBL] [Abstract][Full Text] [Related]
8. Maintenance of large numbers of virus-specific CD8+ T cells in HIV-infected progressors and long-term nonprogressors.
Gea-Banacloche JC; Migueles SA; Martino L; Shupert WL; McNeil AC; Sabbaghian MS; Ehler L; Prussin C; Stevens R; Lambert L; Altman J; Hallahan CW; de Quiros JC; Connors M
J Immunol; 2000 Jul; 165(2):1082-92. PubMed ID: 10878387
[TBL] [Abstract][Full Text] [Related]
9. Phenotype and functional characteristics of HIV-specific cytotoxic CD8+ T cells in chronically infected patients: dual effects of highly active antiretroviral therapy.
Benito JM; López M; Lozano S; Martinez P; Kuroda M; González-Lahoz J; Soriano V
J Acquir Immune Defic Syndr; 2003 Nov; 34(3):255-66. PubMed ID: 14600569
[TBL] [Abstract][Full Text] [Related]
10. Human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy maintain activated CD8+ T cell subsets as a strong adaptive immune response to cytomegalovirus.
Villacres MC; Lacey SF; La Rosa C; Krishnan R; Auge C; Longmate J; Zaia JA; Leedom JM; Diamond DJ
J Infect Dis; 2001 Aug; 184(3):256-67. PubMed ID: 11443550
[TBL] [Abstract][Full Text] [Related]
11. High viral burden in the presence of major HIV-specific CD8(+) T cell expansions: evidence for impaired CTL effector function.
Kostense S; Ogg GS; Manting EH; Gillespie G; Joling J; Vandenberghe K; Veenhof EZ; van Baarle D; Jurriaans S; Klein MR; Miedema F
Eur J Immunol; 2001 Mar; 31(3):677-86. PubMed ID: 11241270
[TBL] [Abstract][Full Text] [Related]
12. Changes in CD4+ and CD8+ T cell subsets in response to highly active antiretroviral therapy in HIV type 1-infected patients with prior protease inhibitor experience.
Gray CM; Schapiro JM; Winters MA; Merigan TC
AIDS Res Hum Retroviruses; 1998 May; 14(7):561-9. PubMed ID: 9591710
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive screening for human immunodeficiency virus type 1 subtype-specific CD8 cytotoxic T lymphocytes and definition of degenerate epitopes restricted by HLA-A0207 and -C(W)0304 alleles.
Currier JR; deSouza M; Chanbancherd P; Bernstein W; Birx DL; Cox JH
J Virol; 2002 May; 76(10):4971-86. PubMed ID: 11967314
[TBL] [Abstract][Full Text] [Related]
14. Identification of effector-memory CMV-specific T lymphocytes that kill CMV-infected target cells in an HLA-E-restricted fashion.
Mazzarino P; Pietra G; Vacca P; Falco M; Colau D; Coulie P; Moretta L; Mingari MC
Eur J Immunol; 2005 Nov; 35(11):3240-7. PubMed ID: 16224817
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive analysis of human immunodeficiency virus type 1 (HIV-1)-specific gamma interferon-secreting CD8+ T cells in primary HIV-1 infection.
Cao J; McNevin J; Holte S; Fink L; Corey L; McElrath MJ
J Virol; 2003 Jun; 77(12):6867-78. PubMed ID: 12768006
[TBL] [Abstract][Full Text] [Related]
16. A fractal clonotype distribution in the CD8+ memory T cell repertoire could optimize potential for immune responses.
Naumov YN; Naumova EN; Hogan KT; Selin LK; Gorski J
J Immunol; 2003 Apr; 170(8):3994-4001. PubMed ID: 12682227
[TBL] [Abstract][Full Text] [Related]
17. Alterations in T cell phenotype and human immunodeficiency virus type 1-specific cytotoxicity after potent antiretroviral therapy.
Seth A; Markee J; Hoering A; Sevin A; Sabath DE; Schmitz JE; Kuroda MJ; Lifton MA; Hirsch MS; Collier AC; Letvin NL; McElrath MJ
J Infect Dis; 2001 Mar; 183(5):722-9. PubMed ID: 11181148
[TBL] [Abstract][Full Text] [Related]
18. Functional heterogeneity of cytokines and cytolytic effector molecules in human CD8+ T lymphocytes.
Sandberg JK; Fast NM; Nixon DF
J Immunol; 2001 Jul; 167(1):181-7. PubMed ID: 11418647
[TBL] [Abstract][Full Text] [Related]
19. The functional profile of primary human antiviral CD8+ T cell effector activity is dictated by cognate peptide concentration.
Betts MR; Price DA; Brenchley JM; Loré K; Guenaga FJ; Smed-Sorensen A; Ambrozak DR; Migueles SA; Connors M; Roederer M; Douek DC; Koup RA
J Immunol; 2004 May; 172(10):6407-17. PubMed ID: 15128832
[TBL] [Abstract][Full Text] [Related]
20. Proliferative capacity of epitope-specific CD8 T-cell responses is inversely related to viral load in chronic human immunodeficiency virus type 1 infection.
Day CL; Kiepiela P; Leslie AJ; van der Stok M; Nair K; Ismail N; Honeyborne I; Crawford H; Coovadia HM; Goulder PJ; Walker BD; Klenerman P
J Virol; 2007 Jan; 81(1):434-8. PubMed ID: 17050606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
